Citigroup Inc Anixa Biosciences Inc Call Options Transaction History
Citigroup Inc
- $217 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIX
# of Institutions
71Shares Held
5.44MCall Options Held
10.3KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.42MShares$5.89 Million0.0% of portfolio
-
D.A. Davidson & Co.614KShares$2.54 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC597KShares$2.47 Million0.34% of portfolio
-
Ubs Group Ag474KShares$1.96 Million0.0% of portfolio
-
Mission Wealth Management, LP356KShares$1.47 Million0.02% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $127M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...